TP53 and invasive ductal breast carcinoma: By using optimised IHC conditions for each of the antibodies, 108 breast cancer specimens comprising 31 Grade 1, 24 Grade 2 and 53 Grade 3 invasive ductal carcinomas were immunostained, and p53 isoform expression patterns were investigated (Figure 2A).